Where does Acadia Healthcare's income statement data come from?

Every line is extracted from Acadia Healthcare's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

	Q1 '26	Q4 '25	Q3 '25	Q2 '25	Q1 '25
Net interest income	-$38.33M-1.1%	-$37.93M-3.6%	-$36.62M-4.2%	-$35.14M-20.4%	-$29.18M+3.0%
Total revenue	$828.8M+0.9%	$821.46M-3.5%	$851.57M-2.0%	$869.23M+12.8%	$770.51M-0.5%
Compensation and benefits	$467.04M+1.3%	$460.85M-0.3%	$462.17M+2.2%	$452.42M+1.6%	$445.27M+4.6%
Occupancy and equipment	$11.73M-2.4%	$12.02M+2.4%	$11.74M-6.9%	$12.61M+8.2%	$11.66M-0.5%
Professional fees	$53.2M+10.1%	$48.33M-6.1%	$51.48M+3.0%	$49.96M+9.3%	$45.71M-3.7%
Depreciation and amortization	$52.43M+14.6%	$45.75M-3.6%	$47.47M-3.1%	$49M+4.2%	$47.03M+18.9%
Goodwill impairment	——	$249.05M0.0%	$249.05M0.0%	$249.05M0.0%	$249.05M—
Acquisition and integration costs	$22.01M-12.7%	$25.21M-41.3%	$42.92M-33.4%	$64.43M+107%	$31.07M+5.1%
Other operating expenses	$131.08M-25.6%	$176.11M+36.7%	$128.79M-4.2%	$134.41M+17.9%	$114M-3.3%
Total costs & expenses	$817.84M-58.9%	$1.99B+145%	$811.59M-0.9%	$819.23M+8.2%	$757.04M+2.8%
Other income (expense), net	-$401K—	——	-$779K+26.2%	-$1.06M-1,345%	-$73K—
Gain (loss) on extinguishment of debt	——	——	——	——	-$1.27M—
Gain (loss) on disposal of assets	$1.22M—	——	——	$8.72M—	——
Income before income taxes	$10.96M+101%	-$1.17B-3,025%	$39.99M-20.0%	$50M+271%	$13.47M-64.6%
Income tax expense	$6.5M-17.1%	$7.84M+370%	$1.67M-86.2%	$12.07M+174%	$4.4M-1.7%
Net income	$4.11M+100%	-$1.18B-3,349%	$36.25M+20.3%	$30.13M+260%	$8.37M-74.3%
Net margin	0.5%+144pp	-143.3%-148pp	4.3%+0.8pp	3.5%+2.4pp	1.1%-3.1pp
Net income attributable to noncontrolling interests	$359K—	——	$2.07M-73.5%	$7.81M+1,032%	$690K—
Diluted earnings per share	$0.05+100%	-$12.98-3,345%	$0.40+21.2%	$0.33+267%	$0.09-75.0%
Basic earnings per share	$0.05+100%	-$12.98-3,345%	$0.40+21.2%	$0.33+267%	$0.09-74.3%
Weighted-average shares, diluted	90.9M+0.2%	90.7M+0.1%	90.6M+0.2%	90.4M-1.7%	92M0.0%
Weighted-average shares, basic	90.5M-0.2%	90.7M+0.3%	90.4M+0.1%	90.3M-1.4%	91.7M0.0%
Adjustments To Additional Paid In Capital Other	——	——	$262K-62.1%	$692K—	——
Share-based compensation expense related to employee stock plans	$7.96M+23.3%	$6.45M+7.0%	$6.03M-42.8%	$10.55M+21.6%	$8.68M-14.1%
Amortization Of Financing Costs	$1.25M-7.3%	$1.35M+9.4%	$1.24M+1.1%	$1.22M+15.7%	$1.06M+2.8%
Business Exit Costs1	$4.96M—	——	$3.21M-68.2%	$10.07M+365%	$2.17M—
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation	$25.23M—	——	——	$40.19M+169%	$14.93M—
Contract With Customer Liability Revenue Unrecognized	——	——	——	——	$14.3M+389%
Deferred taxes	$10.34M—	——	$12.06M+485%	-$3.13M+44.3%	-$5.62M-149%
Effective tax rates	$0.59—	——	$0.04-82.6%	$0.24-26.3%	$0.33—
Fair Value Of Assets Acquired	$17.29M+2.1%	$16.93M+0.6%	$16.83M+14,797%	$113K-99.4%	$19.77M—
Gain/(loss) on dispositions, net	$1.22M—	——	——	$8.72M—	——
Goodwill Additions	$5.07M-73.7%	$19.27M—	——	——	$8.56M—
Goodwill impairment losses	——	$249.05M0.0%	$249.05M0.0%	$249.05M0.0%	$249.05M—
Government Investigations	$12.42M—	——	$38.74M-27.6%	$53.53M+72.6%	$31.01M—
Accounts payable and other current liabilities	$24.4M—	——	$5.9M-84.0%	$36.93M+500%	-$9.24M+42.1%
Increase (Decrease) in Accounts Receivable	$31.15M+209%	$10.07M-54.9%	$22.3M+91.1%	$11.67M-62.4%	$30.99M—
Accrued compensation and employee benefits	-$34.57M-261%	$21.52M+137%	$9.1M-42.6%	$15.86M+180%	-$19.8M-242%
Increase (Decrease) in Other Current Assets	-$27.5M-193%	$29.62M+115%	$13.79M—	——	$9.02M+118%
Increase (decrease) in other current liabilities	$270K-99.6%	$70.74M—	——	$4.27M-74.4%	$16.69M+379%
Increase (decrease) in other assets	$542K+27.2%	$426K-86.6%	$3.18M-50.8%	$6.47M+433%	$1.21M—
Interest Income (Expense), Operating	-$38.33M-1.1%	-$37.93M-3.6%	-$36.62M-4.2%	-$35.14M-20.4%	-$29.18M+3.0%
Legal Accounting And Other Acquisition Related Costs	$716K—	——	$976K+18.3%	$825K+139%	-$2.11M—
Settlement amount awarded	——	——	——	——	——
Management Transition Costs	$3.91M—	——	$0—	——	——
Cash Provided by (Used in) Financing Activity, Including Discontinued Operation	$23.91M-87.6%	$193.28M+341%	$43.82M-23.7%	$57.46M-69.2%	$186.69M+131%
Cash Provided by (Used in) Investing Activity, Including Discontinued Operation	-$60.21M+34.9%	-$92.44M+28.8%	-$129.76M+13.9%	-$150.78M+17.7%	-$183.24M+9.9%
Cash Provided by (Used in) Operating Activity, Including Discontinued Operation	$61.53M—	——	$73.21M-45.2%	$133.5M+1,063%	$11.48M-90.2%
Net Income Loss Attributable To Noncontrolling Interest	$359K—	——	$2.07M-73.5%	$7.81M+1,032%	$690K—
Net Income Loss Attributable To Redeemable Noncontrolling Interest	$359K+28.7%	$279K-86.5%	$2.07M-73.5%	$7.81M+1,032%	$690K—
Number Of Facilities	275—	——	40.0%	4-98.5%	270—
Number Of Facilities Operated By Non Wholly Owned Subsidiaries	17—	——	3—	——	12—
Number of reportable segments	1—	——	——	——	1—
Occupancy and Related Charges	$11.73M-2.4%	$12.02M+2.4%	$11.74M-6.9%	$12.61M+8.2%	$11.66M-0.5%
Other Noncash Income (Expense)	-$401K—	——	-$779K+26.2%	-$1.06M-1,345%	-$73K-110%
Payment for (Proceeds from) Other Investing Activity	$30K—	——	$44K-2.2%	$45K-19.6%	$56K+27.3%
Payments for Repurchase of Common Stock	——	——	——	$3.15M-93.3%	$46.88M—
Payments of Debt Issuance Costs	——	——	——	——	$18.62M—
Payments Of Distributions To Affiliates	——	——	$1.89M—	——	——
Payments Of Dividends Minority Interest	——	——	$1.89M—	——	——
Payments to Acquire Businesses, Net of Cash Acquired	——	——	——	——	$8.59M—
Payments to Acquire Property, Plant, and Equipment	$76.56M-17.8%	$93.19M-31.6%	$136.24M-18.8%	$167.75M-3.9%	$174.63M-14.2%
Proceeds From Contributions From Affiliates	$743K-79.6%	$3.64M—	——	——	——
Dividends received from unconsolidated affiliates	$18.03M-16.8%	$21.68M-9.3%	$23.91M+227%	$7.3M-50.0%	$14.61M—
Debt issued (Note 13)	——	——	——	——	$1.2B—
Financing — other	-$26K-13.0%	-$23K—	$0+100%	-$49K-133%	-$21K—
Proceeds From Payments For Repurchase Of Shares For Payroll Tax Withholding Net Of Proceeds From Stock Option Exercises	-$2.74M—	——	-$237K+86.7%	-$1.78M+8.1%	-$1.94M—
Dispositions of property, plant, and equipment	$16.38M+2,251%	$697K-89.3%	$6.53M-60.6%	$16.58M+38,458%	$43K-79.3%
Redeemable Noncontrolling Interest Resulting From An Acquisition	$17.29M+0.3%	$17.23M+4.5%	$16.48M—	$0-100%	$10.87M—
Repayments of Long-term Lines of Credit	$55M—	——	——	——	$1.04B—
Repayments of Secured Debt	$4.06M—	——	$4.06M—	——	——
Payments on debt	——	——	——	——	$670.86M—
Repurchase Of Shares For Payroll Tax Withholding Net Of Proceeds From Stock Option Exercises	-$2.74M-905%	-$273K-15.2%	-$237K+86.7%	-$1.78M+8.1%	-$1.94M-260%
Revenue From Contract With Customer Excluding Assessed Tax	$828.8M+0.9%	$821.46M-3.5%	$851.57M-2.0%	$869.23M+12.8%	$770.51M-0.5%
Stock-based compensation	$7.96M+23.3%	$6.45M+7.0%	$6.03M-42.8%	$10.55M+21.6%	$8.68M-14.1%
Granted (in shares)	1.1M—	——	——	——	0-100%
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period	24.4K-86.9%	185.6K—	——	——	39.3K-54.7%
Forfeited or expired (in shares)	$61.91+12.6%	$55.00—	——	——	$57.51-14.0%
Granted (in shares)	$11.68—	——	——	——	——
Value of shares repurchased	——	-$4K+55.6%	-$9K-100%	$3.16M-93.3%	$47.27M—
Supplies Expense	$29.49M-4.1%	$30.76M+1.1%	$30.41M+6.6%	$28.53M+0.7%	$28.34M-0.8%
Unrecognized tax benefit, penalty expense (benefit)	$46.9M—	——	——	——	$83.6M—
Add: dilutive effect of potential common shares (in shares)	$329K—	——	$170K+58.9%	$107K-72.1%	$384K—
EBITDA	$63.39M+106%	-$1.12B-1,385%	$87.45M-11.7%	$99M+63.6%	$60.5M-22.0%
EBITDA margin	7.6%+144pp	-136.8%-147pp	10.3%-1.1pp	11.4%+3.5pp	7.9%-2.2pp
EBIT	$10.96M+101%	-$1.17B-3,025%	$39.99M-20.0%	$50M+271%	$13.47M-64.6%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where does Acadia Healthcare's income statement data come from?: Every line is extracted from Acadia Healthcare's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.